Absci (ABSI) Other Non-Current Assets (2020 - 2026)

Absci's (ABSI) quarterly Other Non-Current Assets came in at $383000.0 in Q1 2026, down 63.66% year-on-year from $1.1 million in Q1 2025, and down 63.63% quarter-over-quarter from $1.1 million in Q4 2025.

Absci (ABSI) Other Non-Current Assets (2020 - 2026) Analysis & Trends

Absci has disclosed Other Non-Current Assets across 7 years of filings, most recently posting $383000.0 for Q1 2026.

  • Other Non-Current Assets for Q1 2026 came in at $383000.0, down 63.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $383000.0 (down 63.66% YoY), and the FY2025 annual result was $1.1 million, changed 0.09% from the prior year.
  • Other Non-Current Assets came in at $383000.0 for Q1 2026 at Absci, down from $1.1 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $16.5 million in Q2 2024 to a low of $383000.0 in Q1 2026.
  • The 5-year median for Other Non-Current Assets is $1.3 million (2022), against an average of $6.3 million.
  • Across the five-year window, Other Non-Current Assets jumped 1338.89% in 2024 and slumped 93.34% in 2025, its largest moves.
  • Absci's Other Non-Current Assets stood at $15.0 million in 2022, then sank by 92.6% to $1.1 million in 2023, then retreated by 5.22% to $1.1 million in 2024, then dropped by 0.09% to $1.1 million in 2025, then plunged by 63.63% to $383000.0 in 2026.
  • The last three Other Non-Current Assets figures came in at $383000.0 (Q1 2026), $1.1 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 12.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 60,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Absci 1.13 Bn 1.01 Bn - 383,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 383,000.00
Dec 31, 2025 1.05 Mn
Sep 30, 2025 1.05 Mn
Jun 30, 2025 16.21 Mn
Mar 31, 2025 1.05 Mn
Dec 31, 2024 1.05 Mn
Sep 30, 2024 15.80 Mn
Jun 30, 2024 16.51 Mn
Mar 31, 2024 1.13 Mn
Dec 31, 2023 1.11 Mn
Sep 30, 2023 1.10 Mn
Jun 30, 2023 15.07 Mn
Mar 31, 2023 15.03 Mn
Dec 31, 2022 15.02 Mn
Sep 30, 2022 1.85 Mn
Jun 30, 2022 1.34 Mn
Mar 31, 2022 1.84 Mn
Dec 31, 2021 16.84 Mn
Sep 30, 2021 10.51 Mn
Jun 30, 2021 10.50 Mn